Creatine deficiency syndromes and the importance of creatine synthesis in the brain
Open Access
- 10 March 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Amino Acids
- Vol. 40 (5), 1315-1324
- https://doi.org/10.1007/s00726-011-0852-z
Abstract
Creatine deficiency syndromes, due to deficiencies in AGAT, GAMT (creatine synthesis pathway) or SLC6A8 (creatine transporter), lead to complete absence or very strong decrease of creatine in CNS as measured by magnetic resonance spectroscopy. Brain is the main organ affected in creatine-deficient patients, who show severe neurodevelopmental delay and present neurological symptoms in early infancy. AGAT- and GAMT-deficient patients can be treated by oral creatine supplementation which improves their neurological status, while this treatment is inefficient on SLC6A8-deficient patients. While it has long been thought that most, if not all, of brain creatine was of peripheral origin, the past years have brought evidence that creatine can cross blood-brain barrier, however, only with poor efficiency, and that CNS must ensure parts of its creatine needs by its own endogenous synthesis. Moreover, we showed very recently that in many brain structures, including cortex and basal ganglia, AGAT and GAMT, while found in every brain cell types, are not co-expressed but are rather expressed in a dissociated way. This suggests that to allow creatine synthesis in these structures, guanidinoacetate must be transported from AGAT- to GAMT-expressing cells, most probably through SLC6A8. This new understanding of creatine metabolism and transport in CNS will not only allow a better comprehension of brain consequences of creatine deficiency syndromes, but will also contribute to better decipher creatine roles in CNS, not only in energy as ATP regeneration and buffering, but also in its recently suggested functions as neurotransmitter or osmolyte.Keywords
This publication has 92 references indexed in Scilit:
- Response to creatine analogs in fibroblasts and patients with creatine transporter deficiencyMolecular Genetics and Metabolism, 2010
- Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouseBMC Developmental Biology, 2009
- Evolution of the Neurochemical Profile after Transient Focal Cerebral Ischemia in the Mouse BrainJournal of Cerebral Blood Flow & Metabolism, 2009
- Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivoAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Arginine supplementation in four patients with X‐linked creatine transporter defectJournal of Inherited Metabolic Disease, 2008
- Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: Early treatment can prevent phenotypic expression of the diseaseThe Journal of Pediatrics, 2006
- X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiologyHuman Genetics, 2006
- Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiencyNeuroscience Letters, 1996
- The Putative Rat Choline Transporter CHOT1 Transports Creatine and Is Highly Expressed in Neural and Muscle-Rich TissuesBiochemical and Biophysical Research Communications, 1994
- Brain Tissue Concentrations of ATP, Phosphocreatine, Lactate, and Tissue pH in Relation to Reduced Cerebral Blood Flow following Experimental Acute Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1988